Search research articles
Contact Us
Filters
Showing results (111-120 of 254) with videos related to
Page
of 26
Sort By:
Acta Crystallographica. Section D, Biological Crystallography
|
September 1, 1993
Determination of three crystal structures of canavalin by molecular replacement
T P Ko, J D Ng, J Day, et al.
Plant Molecular Biology
|
January 1, 1992
PCR cloning of the full-length cDNA for the seed protein canavalin from the jack bean plant, Canavalis ensiformis
J D Ng, T Stinchcombe, T P Ko, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 11, 2009
Comparison of injection pain of articaine and lidocaine in eyelid surgery
Eric A Steele, John D Ng, Tasha M Poissant, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
February 12, 2014
Elevated white blood cell count may predict risk of orbital implant exposure
Youn-Shen Bee, Muh-Chiou Lin, Shwu-Jiuan Sheu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1998
Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements
D Ng, N Kokot, T Hiura, et al.
The British Journal of Surgery
|
June 1, 1985
Reversible stenosis of the renal artery following renal transplantation
Y T Chan, W D Ng, C P Ho, et al.
Ocular Oncology and Pathology
|
November 27, 2019
Orbital Cellular Epithelioid Hemangioma
Hillary C Stiefel, John D Ng, David J Wilson, et al.
American Journal of Epidemiology
|
April 3, 1998
Re: "p53 protein overexpression in relation to risk factors for breast cancer"
M B Terry, M D Gammon, D Ng-Mak, et al.
Advances in Therapy
|
August 28, 2025
Real-World Weight Loss Observed With Semaglutide and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE)
Carmen D Ng, Victoria Divino, Julia Wang, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 24, 2021
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data
Natalie J Engmann, Danny Sheinson, Komal Bawa, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 254) with videos related to
Sort By:
Page
of 26
Acta Crystallographica. Section D, Biological Crystallography
|
September 1, 1993
Determination of three crystal structures of canavalin by molecular replacement
T P Ko, J D Ng, J Day, et al.
Plant Molecular Biology
|
January 1, 1992
PCR cloning of the full-length cDNA for the seed protein canavalin from the jack bean plant, Canavalis ensiformis
J D Ng, T Stinchcombe, T P Ko, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 11, 2009
Comparison of injection pain of articaine and lidocaine in eyelid surgery
Eric A Steele, John D Ng, Tasha M Poissant, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
February 12, 2014
Elevated white blood cell count may predict risk of orbital implant exposure
Youn-Shen Bee, Muh-Chiou Lin, Shwu-Jiuan Sheu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1998
Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements
D Ng, N Kokot, T Hiura, et al.
The British Journal of Surgery
|
June 1, 1985
Reversible stenosis of the renal artery following renal transplantation
Y T Chan, W D Ng, C P Ho, et al.
Ocular Oncology and Pathology
|
November 27, 2019
Orbital Cellular Epithelioid Hemangioma
Hillary C Stiefel, John D Ng, David J Wilson, et al.
American Journal of Epidemiology
|
April 3, 1998
Re: "p53 protein overexpression in relation to risk factors for breast cancer"
M B Terry, M D Gammon, D Ng-Mak, et al.
Advances in Therapy
|
August 28, 2025
Real-World Weight Loss Observed With Semaglutide and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE)
Carmen D Ng, Victoria Divino, Julia Wang, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 24, 2021
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data
Natalie J Engmann, Danny Sheinson, Komal Bawa, et al.
Page
of 26